CAT No: C5501
CAS No:188968-51-6
Synonyms/Alias:Cilengitide;188968-51-6;EMD-121974;2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;Cyclo(L-arginylglycyl-L-alpha-aspartyl-D-phenylalanyl-N-methyl-L-valyl);EMD 121974;Cilengitide [USAN:INN];EMD-12192;EMD121974;Cilengitida;4EDF46E4GI;CILENGITIDE [MI];CILENGITIDE [INN];CILENGITIDE [USAN];CILENGITIDE [MART.];cyclic-Arg-Gly-Asp-D-Phe(N-methyl)Val;CILENGITIDE [WHO-DD];CHEMBL429876;2-((2S,5R,8S,11S)-5-benzyl-11-(3-guanidinopropyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid;DTXSID9044035;cyclo(arginyl-glycyl-formylaspartyl-N-methylvalyl);cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl);CILENGITIDE (MART.);CYCLO(L-ARGINYLGLYCYL-L-.ALPHA.-ASPARTYL-D-PHENYLALANYL-N-METHYL-L-VALYL);2-[(2S,5R,8S,11S)-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-5-(phenylmethyl)-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;2-[(2S,5R,8S,11S)-5-benzyl-11-(3-carbamimidamidopropyl)-7-methyl-3,6,9,12,15-pentaoxo-8-(propan-2-yl)-1,4,7,10,13-pentaazacyclopentadecan-2-yl]acetic acid;C27H40N8O7;cyclo(RGDf-N(Me)V);UNII-4EDF46E4GI;cilengitidum;cyclo-(Arg-Gly-Asp-DPhe-NMeVal);Cilengitide?;NSC-707544;Cyclo(L-arginylglycyl-L-aspartyl-D-phenylalanyl-N-methyl-L-valyl);[(2S,5R,8S,11S)-5-BENZYL-11-(3-CARBAMIMIDAMIDOPROPYL)-8-ISOPROPYL-7-METHYL-3,6,9,12,15-PENTAOXO-1,4,7,10,13-PENTAAZACYCLOPENTADECAN-2-YL]ACETIC ACID;2-((2S,5R,8S,11S)-11-(3-(diaminomethylideneamino)propyl)-7-methyl-3,6,9,12,15-pentaoxo-5-(phenylmethyl)-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl)acetic acid;2-((2S,5R,8S,11S)-5-benzyl-11-(3-carbamimidamidopropyl)-7-methyl-3,6,9,12,15-pentaoxo-8-(propan-2-yl)-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid;Cilengitide trifluoroacetic acid salt;c(RGDfMeV);Cilengitide (USAN/INN);SCHEMBL34082;GTPL6597;DTXCID7024035;CHEBI:177833;EX-A1775;NHA96851;BDBM50235980;NSC774651;s6387;AKOS024257893;AKOS030525213;CS-1211;cyclo(Arg-Gly-Asp-D-Phe-[N-Me]Val);DB11890;NSC-774651;NCGC00386242-02;NCGC00386242-04;AC-35857;AS-72195;DA-51902;HY-16141;NS00069654;SW220134-1;A11657;D03497;Q1091921;BRD-K57252450-001-02-5;[(2S,5R,8S,11S)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13pentaaza-cyclopentadec-2-yl]-acetic acid;
2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More